Iovance Biotherapeutics Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.63 (market cap $6.04B), while Vishay Intertechnology Inc. Common Stock trades at $34.24 (market cap $5.30B). The key difference: Iovance Biotherapeutics Inc. Common Stock and Vishay Intertechnology Inc. Common Stock are close in size by market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.16% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Vishay Intertechnology Inc. Common Stock for 1 Days on average.
| IOVA | VSH | |
|---|---|---|
Market Cap | $6.04B | $5.30B |
Volume | 14,805,993 | 3,213,272 |
Sector | Health | Technology |
52-Week High | $14.82 | $64.90 |
52-Week Low | $1.81 | $11.82 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $5.10B |
Dividend Yield | — | 1.16% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →